Insider Transactions Reported by 21 Insiders of Matinas BioPharma Holdings, Inc.

Symbol
MTNB on NYSE
Location
Bedminster, NJ

There are no Buy or Sell transactions made by insiders since 06 Jan 2025

Matinas BioPharma Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
ROBERT J. EIDE 10%+ Owner 08 Apr 2025
Robin Smith Director 30 Apr 2025
EDWARD NEUGEBOREN Director 30 Apr 2025
Keith Murphy Director 30 Apr 2025
Eric J. Ende Director 01 Nov 2023
Pembroke & Partners LLC 10%+ Owner 08 Apr 2025
Sanitam Partners LLC 10%+ Owner 08 Apr 2025
An Evelyn D. Director 30 Apr 2025
ADAM STERN 10%+ Owner 13 Feb 2025
MATTHEW WIKLER Director 01 Nov 2023
RAPHAEL J. MANNINO Chief Scientific Officer 14 Dec 2021
Natasha Giordano Director 01 Nov 2023
James S. Scibetta Director 01 Nov 2023
Jerome D. Jabbour President and CEO, Director 30 Apr 2025
Kathryn Penkus Corzo Director 01 Nov 2023
Thomas Hoover Chief Business Officer 15 Dec 2023
James J. Ferguson III Chief Medical Officer 15 Dec 2023
Theresa Matkovits Chief Development Officer 15 Dec 2023
Hui Liu Chief Technology Officer 15 Dec 2023
Keith A. Kucinski Chief Financial Officer 15 Dec 2023
HERBERT J. CONRAD Director 01 Nov 2023

Recent Insider Transactions by Companies or Individuals for Matinas BioPharma Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.